NCT02772549Active, not recruiting
Early Diagnosis of Pulmonary Fibrosis - Diagnostic Delay
Early Diagnosis of Pulmonary Fibrosis
Source: ClinicalTrials.gov · Last updated 22 Dec 2023
Brief summary (registry, in English)
Patients with newly diagnosed IPF are investigated for the diagnostic delay before a diagnosis of IPF is made.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 10 May 2016
- Start date
- Mar 2016
- Primary completion date
- Dec 2022
- Lead sponsor
- Nils Hoyer
- Diseases
- Idiopathic pulmonary fibrosis
- NCT number
- NCT02772549
What you commit to
- Study type: Observational
- Planned participants: 300
- From Mar 2016 to the primary completion date, Dec 2022
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age below 18 years
Other
- Unable to provide written informed consent
Who the study is looking for
- Diagnosis of IPF according to international guidelines
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aarhus University Hospital Coordinator of this site? Confirm its status | Aarhus | Denmark | Unknown status |
| Gentofte Hospital Coordinator of this site? Confirm its status | Hellerup | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.